Goldman Sachs’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.9M | Sell |
56,100
-22,000
| -28% | -$11.1M | ﹤0.01% | 2183 |
|
|
2025
Q4 | $44.2M | Buy |
78,100
+48,700
| +166% | +$25.9M | 0.01% | 1607 |
|
|
2025
Q3 | $13.1M | Sell |
29,400
-7,900
| -21% | -$3.79M | ﹤0.01% | 2694 |
|
|
2025
Q2 | $20.3M | Sell |
37,300
-4,700
| -11% | -$2.46M | ﹤0.01% | 2113 |
|
|
2025
Q1 | $20.8M | Buy |
42,000
+30,000
| +250% | +$16.6M | ﹤0.01% | 1991 |
|
|
2024
Q4 | $6.26M | Buy |
+12,000
| New | +$6.25M | ﹤0.01% | 3223 |
|
|
2024
Q1 | – | Sell |
-7,900
| Closed | -$2.67M | – | 5717 |
|
|
2023
Q4 | $2.67M | Sell |
7,900
-100
| -1% | -$29.8K | ﹤0.01% | 3693 |
|
|
2023
Q3 | $2.34M | Sell |
8,000
-2,000
| -20% | -$625K | ﹤0.01% | 3649 |
|
|
2023
Q2 | $3.42M | Buy |
+10,000
| New | +$3.03M | ﹤0.01% | 3432 |
|
|
2023
Q1 | – | Sell |
-12,500
| Closed | -$3.32M | – | 6079 |
|
|
2022
Q4 | $3.32M | Buy |
+12,500
| New | +$3.05M | ﹤0.01% | 3528 |
|
|
2022
Q1 | – | Sell |
-19,500
| Closed | -$7.01M | – | 6729 |
|
|
2021
Q4 | $7.01M | Buy |
+19,500
| New | +$6.71M | ﹤0.01% | 3096 |
|
|
2021
Q3 | – | Sell |
-15,900
| Closed | -$4.87M | – | 6359 |
|
|
2021
Q2 | $4.87M | Sell |
15,900
-5,700
| -26% | -$1.6M | ﹤0.01% | 3364 |
|
|
2021
Q1 | $5.32M | Buy |
21,600
+14,400
| +200% | +$3.62M | ﹤0.01% | 3086 |
|
|
2020
Q4 | $1.96M | Sell |
7,200
-15,000
| -68% | -$3.72M | ﹤0.01% | 3746 |
|
|
2020
Q3 | $5.25M | Buy |
22,200
+3,300
| +17% | +$741K | ﹤0.01% | 2854 |
|
|
2020
Q2 | $3.59M | Sell |
18,900
-15,300
| -45% | -$2.74M | ﹤0.01% | 3028 |
|
|
2020
Q1 | $5.64M | Buy |
34,200
+15,600
| +84% | +$2.86M | ﹤0.01% | 2545 |
|
|
2019
Q4 | $3.67M | Buy |
18,600
+300
| +2% | +$56.2K | ﹤0.01% | 3198 |
|
|
2019
Q3 | $3.29M | Sell |
18,300
-3,600
| -16% | -$623K | ﹤0.01% | 3170 |
|
|
2019
Q2 | $3.83M | Sell |
21,900
-15,000
| -41% | -$2.57M | ﹤0.01% | 3045 |
|
|
2019
Q1 | $7.02M | Sell |
36,900
-10,500
| -22% | -$1.87M | ﹤0.01% | 2717 |
|
|
2018
Q4 | $7.57M | Sell |
47,400
-15,000
| -24% | -$2.54M | ﹤0.01% | 2544 |
|
|
2018
Q3 | $11.9M | Buy |
62,400
+14,700
| +31% | +$2.61M | ﹤0.01% | 2315 |
|
|
2018
Q2 | $7.61M | Sell |
47,700
-12,000
| -20% | -$1.83M | ﹤0.01% | 2634 |
|
|
2018
Q1 | $8.21M | Sell |
59,700
-306,900
| -84% | -$42.8M | ﹤0.01% | 2501 |
|
|
2017
Q4 | $44.6M | Sell |
366,600
-1,943,700
| -84% | -$243M | 0.01% | 1373 |
|
|
2017
Q3 | $268M | Buy |
2,310,300
+195,300
| +9% | +$21.3M | 0.07% | 315 |
|
|
2017
Q2 | $220M | Sell |
2,115,000
-263,700
| -11% | -$25.3M | 0.06% | 365 |
|
|
2017
Q1 | $203M | Buy |
2,378,700
+1,816,200
| +323% | +$143M | 0.06% | 382 |
|
|
2016
Q4 | $39.6M | Buy |
562,500
+58,500
| +12% | +$4.3M | 0.01% | 1425 |
|
|
2016
Q3 | $40.6M | Sell |
504,000
-61,200
| -11% | -$4.69M | 0.01% | 1364 |
|
|
2016
Q2 | $41.5M | Buy |
565,200
+176,400
| +45% | +$12.4M | 0.01% | 1251 |
|
|
2016
Q1 | $26M | Buy |
388,800
+150,300
| +63% | +$9.31M | 0.01% | 1528 |
|
|
2015
Q4 | $14.5M | Sell |
238,500
-105,300
| -31% | -$5.91M | ﹤0.01% | 1983 |
|
|
2015
Q3 | $17.6M | Sell |
343,800
-900
| -0.3% | -$51K | 0.01% | 1804 |
|
|
2015
Q2 | $18.6M | Sell |
344,700
-27,900
| -7% | -$1.56M | 0.01% | 1849 |
|
|
2015
Q1 | $20.9M | Sell |
372,600
-59,400
| -14% | -$3.36M | 0.01% | 1717 |
|
|
2014
Q4 | $25.4M | Sell |
432,000
-172,800
| -29% | -$9.62M | 0.01% | 1653 |
|
|
2014
Q3 | $31M | Sell |
604,800
-1,531,800
| -72% | -$76.1M | 0.01% | 1449 |
|
|
2014
Q2 | $97.8M | Buy |
2,136,600
+750,600
| +54% | +$33.1M | 0.03% | 682 |
|
|
2014
Q1 | $67.5M | Buy |
1,386,000
+19,800
| +1% | +$933K | 0.02% | 848 |
|
|
2013
Q4 | $58.3M | Sell |
1,366,200
-1,064,700
| -44% | -$44.8M | 0.02% | 947 |
|
|
2013
Q3 | $102M | Buy |
2,430,900
+467,100
| +24% | +$20.6M | 0.04% | 592 |
|
|
2013
Q2 | $110M | Buy |
+1,963,800
| New | +$108M | 0.04% | 513 |
|
Other funds holding ISRG
VCM
VPM
Goldman Sachs's ISRG Position: Q1 2026 in Review
Goldman Sachs increased its Intuitive Surgical (ISRG) stake by 1.4% in Q1 2026, buying an estimated $16.9M and bringing the position to 2,451,269 shares worth $1.13B. The position accounts for 0.13% of the portfolio, ranked #138.
Goldman Sachs first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.4B in Q3 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- Goldman Sachs held 2,451,269 shares of Intuitive Surgical worth $1.13B as of Q1 2026.
- Goldman Sachs bought 33,473 Intuitive Surgical shares in Q1 2026, an estimated $16.9M.
- Intuitive Surgical made up 0.13% of Goldman Sachs's portfolio in Q1 2026, its #138 holding.
- Goldman Sachs first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Intuitive Surgical position peaked at $1.4B in Q3 2025.
- 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.